The Pearl Effect: How DSOs Scaled Clearer Presentations into $260M in New Revenue

Two independent pilot studies — one longitudinal year-over-year analysis and one concurrent parallel-group study — show that Dental Service Organizations (DSOs) using Pearl's AI strengthen clinical performance and unlock major new revenue. Pearl Second Opinion adds $67,000 to $72,000 in annual revenue per clinic, a 13x to 19x return on investment. Pearl Practice Intelligence adds exponentially more — up to $432,000 per clinic per year, a potential 90x return on investment.

Methodology

Group A: Longitudinal year-over-year analysis across 31 pilot offices over 8 or more weeks.

Group B: Concurrent parallel-group study of 12 Pearl offices and 5 control offices over 11 weeks.

Pearl reversed diagnostic decline

Working with Second Opinion, practitioners identified more needed treatment, more consistently. Before Pearl, wavering clinician confidence and rushed appointments led to a 2% decline in total diagnoses across the network. With Pearl, clinics saw a 9.6% diagnostic reversal — an 11.6 percentage-point year-over-year increase in diagnostic consistency.

Improved case acceptance

Using Second Opinion's AI highlights, clinicians were better able to explain treatment needs and patients accepted more treatment. Case acceptance increased 6.7% overall and 15.7% on a same-day basis.

Uncovered hidden opportunities with Practice Intelligence

With Practice Intelligence analyzing patient records, clinics in the longitudinal study identified 379 untreated opportunities, 203 planned opportunities, and 129 completed treatments per clinic.

The Pearl Effect on ROI

What started as clearer conversations in the chair became a growth engine across the enterprise. Pearl scales with your network — from pilot to enterprise. Second Opinion drives meaningful uplift on its own, but Practice Intelligence delivers a far larger revenue opportunity by surfacing untreated and undiagnosed needs already in the patient base.

• 80 clinics: Second Opinion ~$5.4 million annual uplift; with Practice Intelligence ~$34.6 million annual uplift.
• 161 clinics: Second Opinion ~$10.9 million annual uplift; with Practice Intelligence ~$69.6 million annual uplift.
• 600 clinics: Second Opinion ~$40.6 million annual uplift; with Practice Intelligence ~$259.3 million annual uplift.

Across both studies, Pearl helped clinics strengthen clinical performance. Second Opinion alone added $67,000 to $72,000 per clinic in annual revenue at a 13x to 19x return on investment. Practice Intelligence added exponentially more — up to $432,000 per clinic, a potential 90x return on investment.

Pearl products studied

Pearl Second Opinion is FDA-cleared, AI-powered radiologic software that surfaces dental disease in real time during patient visits, giving clinicians and patients clearer evidence to support treatment decisions. In the studies it lifted diagnostic consistency by 11.6 percentage points year-over-year and improved case acceptance by 6.7% overall and 15.7% same-day.

Pearl Practice Intelligence is AI software that analyzes patient records to identify gaps in care, predict outcomes, and surface untreated treatment opportunities at the practice and enterprise level. By acting on previously hidden opportunities, Practice Intelligence drove up to ~$432,000 in annual revenue per clinic — a potential 90x return on investment.

Who this case study is for

Dental Service Organizations (DSOs) evaluating AI to improve diagnostic consistency, case acceptance, and enterprise-wide revenue. Talk to sales for a personalized DSO revenue report — including location-by-location analysis, case category breakdown, and a 3-year Pearl impact projection.